Evidence map›Paper›PMID 40604916›Full record

ArticleOrphanet journal of rare diseases2025

Childhood to adult transition in youth patients with lysosomal acid lipase deficiency: 43 recommendations from experts.

Alvaro Hermida-Ameijeiras, Javier Blasco-Alonso, Juan Luis Carrillo-Linares, María Luisa González-Dieguez, José Pastor-Rosado, Montserrat Morales-Conejo, Marcello Bellusci, Maria Mercadal-Hally

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alvaro Hermida-AmeijeirasDivision of Internal Medicine, University of Santiago de Compostela. UETeM- Molecular Pathology Group, IDIS-CIMUS, MetabERN, Santiago de Compostela, Spain.
Javier Blasco-AlonsoSection of Pediatric Gastroenterology and Nutrition, Regional University Hospital of Malaga, Malaga, Spain.
Juan Luis Carrillo-LinaresInternal Medicine Department, Virgen de la Victoria University Hospital, Malaga, Spain.
María Luisa González-DieguezLiver Unit, Division of Gastroenterology and Hepatology, Central University Hospital of Asturias, Oviedo, Spain.
José Pastor-RosadoLipid Unit, Department of Pediatrics, General University Hospital of Elche, Miguel Hernandez University of Elche, Elche, Spain.
Montserrat Morales-ConejoInternal Medicine Department, Biomedical Research Center CIBERER, CSUR for Congenital Metabolic Disorders, Octubre University Hospital, Madrid, U723, Spain.
Marcello BellusciReference Center for Inherited Metabolic Disorders, MetabERN Center, 12 de Octubre University Hospital, Madrid, Spain.
Maria Mercadal-HallyPediatric Hepatology and liver transplant Unit, Vall d'Hebron Hospital, Barcelona, Spain. mariamargaret.mercadal@vallhebron.cat.ORCID http://orcid.org/0000-0003-1687-6448

Funding

Alexion Pharma Alexion Pharma
6 · The paper itself

Abstract

backgroundThe process of transition from pediatric to adult care is crucial, especially in rare diseases such as lysosomal acid lipase deficiency (LAL-D). Unfortunately, this process is associated with poor outcomes, and many challenges still await to be addressed. This document provides recommendations on the pediatric to adult care transition in patients with LAL-D, based on available evidence and the experience of a panel of experts, which include specialists in the management of patients with LAL-D, and representative patients of the AELALD patient organization. Additionally, the main uncertainties and/or challenges encountered by the different stakeholders during the process are defined. MAIN BODY: A total of 43 consensus recommendations were developed across 5 areas. The consensus recommendations reflect the personal opinions and experiences of the participating experts supported with evidence when available. Overall, the main uncertainties and/or challenges faced comprise the patient's mistrust in the new medical team, the insufficient information received, or the lack of time, resources and institutional support. The management of adolescents/young adults during the transition to adulthood should be a joint effort between the patient, clinical center, and parents/caregivers. The objective of the transition process should be to empower patients and progressively encourage the self-management of their disease, and therefore patients and their families should be involved in all phases of the transition. Facilitating elements, such as standardized protocols, arose as important tools to ease the transition process.

conclusionsThis multidisciplinary consensus provides information on the main obstacles found by patients and their families, pediatricians and adult physicians during the transition from pediatric to adult care in LAL-D. To overcome these barriers, the scientific committee highlights the need for different facilitating elements, which include an effective collaboration between healthcare teams, the elaboration of standardized protocols, the implementation of education for patients, or the individual evaluation of the need for psychological support. The recommendations provided by the experts are the basis to facilitate and improve the transition process.

Indexed as

Transition to Adult CareWolman DiseaseAdolescentAdultChildHumansYoung AdultAdolescentsLysosomal acid lipase deficiencyMultidisciplinary consensusPediatric to adult care transitionRecommendationsTransition protocol

Identifiers

PMID40604916
PMCPMC12224453

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.